Background: The benefits and efficacy of the influenza vaccine have been controversial and
have had mixed reviews in the recent literature. Immunosuppressed patients and those …

An open, randomised study was performed to determine whether two doses of influenza
vaccine were more effective than one to elicit an immune response in 70 patients with …

A study was conducted to determine if a two-dose regimen of influenza vaccine would
enhance the immunologic response of 41 patients with lymphoma receiving chemotherapy …

Eighty‐two patients with solid tumors and lymphomas were immunized with New Jersey,
Hong Kong, and Victoria influenza vaccines. Patients were divided into groups according to …

Background Cancer patients often experience preventable infections, including influenza A
and B. These infections can be a cause of significant morbidity and mortality. The increased …

Purpose: The purpose of this study was to assess humoral response to influenza vaccine in
patients (pts) with non-Hodgkin lymphoma (NHL) as compared to healthy subjects (ctrl) …

Objective Cancer patients receiving chemotherapy are at risk of acquiring influenza
infections. Two-dose vaccination is a proposed strategy for increasing vaccination efficacy; …

Influenza infection is a potential cause of excess morbidity in patients who are
immunosuppressed because of haemato-oncological malignancy or its treatment. Therefore …

Influenza infection is a potential cause of additional morbidity and mortality in patients who
are immunocompromised because of cancer or its treatment. Of particular note, influenza …

Patients with solid tumours receiving chemotherapy are at risk for influenza complications.
Yearly influenza vaccination is recommended to patients treated with chemotherapy …